Guangdong Hybribio Biotech (300639.SZ) plans to spend 50 million to 100 million yuan to repurchase shares, with the repurchase price not exceeding 9 yuan per share.

20:21 14/11/2024

Capstone Biology (300639.SZ) announced that the company plans to use its own funds and bank special repurchase loan funds in order to concentrate...

Guangdong Hybribio Biotech (300639.SZ) announced that the company plans to use own funds and bank special repurchase loan funds to repurchase some of its shares through centralized competitive trading. The total amount of funds will not be less than RMB 50 million (inclusive) and not exceed RMB 100 million (inclusive). The repurchase price of the shares shall not exceed RMB 9.00 per share (inclusive). The implementation period of the share repurchase shall not exceed 3 months from the date of approval by the board of directors.

K & P INT'L (00675) will distribute a final dividend of 0.02 Hong Kong dollars per share on July 14.

K & P INT'L released its annual performance, with a net loss attributable to shareholders of HK$6.9437 million, representing a 23.33% decrease year-on-year.

SH IND URBAN (00563) announced a net loss attributable to shareholders of HK$962 million for the year 2025, representing a 190.4% increase compared to the previous year.

K & P INT'L (00675) will distribute a final dividend of 0.02 Hong Kong dollars per share on July 14.

K & P INT'L released its annual performance, with a net loss attributable to shareholders of HK$6.9437 million, representing a 23.33% decrease year-on-year.

SH IND URBAN (00563) announced a net loss attributable to shareholders of HK$962 million for the year 2025, representing a 190.4% increase compared to the previous year.